Panagora Asset Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-49,975
Closed -$582K – 1257
2026
Q2
$582K Sell
49,975
-4,987
-9% -$71.2K ﹤0.01% 859
2026
Q1
$923K Buy
54,962
+43,596
+384% +$780K ﹤0.01% 724
2025
Q4
$182K Buy
+11,366
New +$169K ﹤0.01% 1141
2017
Q4
– Sell
-22,986
Closed -$2.27M – 2303
2017
Q3
$2.27M Hold
22,986
– – 0.01% 813
2017
Q2
$2.33M Buy
22,986
+21,997
+2,224% +$2.37M 0.01% 802
2017
Q1
$114K Hold
989
– – ﹤0.01% 1828
2016
Q4
$119K Hold
989
– – ﹤0.01% 1897
2016
Q3
$111K Buy
989
+559
+130% +$64.4K ﹤0.01% 1939
2016
Q2
$53K Hold
430
– – ﹤0.01% 2049
2016
Q1
$48K Sell
430
-24
-5% -$2.49K ﹤0.01% 2022
2015
Q4
$49K Hold
454
– – ﹤0.01% 1986
2015
Q3
$45K Hold
454
– – ﹤0.01% 2017
2015
Q2
$52K Hold
454
– – ﹤0.01% 2130
2015
Q1
$47K Hold
454
– – ﹤0.01% 2100
2014
Q4
$55K Hold
454
– – ﹤0.01% 2016
2014
Q3
$66K Sell
454
-21
-4% -$3.24K ﹤0.01% 1961
2014
Q2
$79K Hold
475
– – ﹤0.01% 1989
2014
Q1
$94K Sell
475
-9,597
-95% -$1.81M ﹤0.01% 1949
2013
Q4
$1.92M Buy
10,072
+1,096
+12% +$204K 0.01% 887
2013
Q3
$1.52M Buy
8,976
+7,567
+537% +$1.17M 0.01% 927
2013
Q2
$214K Buy
+1,409
New +$200K ﹤0.01% 1605

Other funds holding CLB

Panagora Asset Management's CLB Position: Q3 2026 in Review

Panagora Asset Management sold out of Core Laboratories (CLB) in Q3 2026, closing a stake of 49,975 shares — an estimated $582K sold.

Panagora Asset Management first reported a position in CLB in Q2 2013 and held it in 21 quarters. The position peaked at $2.33M in Q2 2017. 131 funds tracked by Wall St. Rank hold CLB as of Q3 2026.

  • Panagora Asset Management reported no remaining Core Laboratories position as of Q3 2026 after selling out during the quarter.
  • Panagora Asset Management sold 49,975 Core Laboratories shares in Q3 2026, an estimated $582K.
  • Panagora Asset Management first reported a position in Core Laboratories in Q2 2013 and held it in 21 quarters.
  • Panagora Asset Management's Core Laboratories position peaked at $2.33M in Q2 2017.
  • 131 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.

Based on Panagora Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.